BTIG analyst Marie Thibault initiates coverage on Haemonetics (NYSE: HAE) with a Buy rating and a price target of $112.00.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE